For the Inventor, By the Inventor

Enter assignee name

Calgary, Canada

Synsorb Biotech, Inc.

USPTO Granted Patents = 34

CIPO Patents = 2

Forward Citations = 123

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Glen D Armstrong (20 out of 38 patents)

Louis D Heerze (13 out of 21 patents)

Ole Hindsgaul (11 out of 29 patents)

4. Bradley G Thompson (3 out of 151 patents)

5. David J Rafter (3 out of 3 patents)

6. Robert M Ratcliffe (3 out of 11 patents)

7. Ulf Nilsson (2 out of 21 patents)

8. Keiko Sujino (2 out of 16 patents)

9. David C Schriemer (2 out of 14 patents)

10. Monica Marija Palcic (2 out of 5 patents)

11. Francois Auclair (2 out of 2 patents)

12. Hermy Lior (2 out of 2 patents)

13. George A Wells (2 out of 2 patents)

14. Andrew M MacKenzie (2 out of 2 patents)

15. Paul R Goodyer (2 out of 2 patents)

Core Competencies:

Sialylated Oligosaccharides

C. Difficile

Bacterial Dysentery

Toxin Binding

Mass Spectrometry

Thio-Oligosaccharides

Galactose Derivatives

Combinatorial Synthesis

Cholera Treatment

Solid Support Matrices

Toxin Removal

Carbohydrate Libraries

34 patents: Sort by Forward Citations

1. 6528274 - Method for the production of sialylated oligosaccharides (2003-03-04),

2. 6465435 - Treatment of C. difficile toxin B associated conditions (2002-10-15),

3. 6358930 - Treatment of C. difficile toxin B associated conditions (2002-03-19),

4. 6224891 - Compounds and methods for the treatment of bacterial dysentery using antibiotics and toxin binding oligosaccharide compositions (2001-05-01),

5. 6194178 - Method for the production of sialylated oligosaccharides (2001-02-27),

6. 6191418 - Device for delivery of multiple liquid sample streams to a mass spectrometer (2001-02-20),

7. 6177553 - Solid phase synthesis of thio-oligosaccharides (2001-01-23),

8. 6174867 - 1-galactose derivatives having a carbon- or nitrogen-containing aglycon linkage (2001-01-16),

9. 6121242 - Treatment of bacterial dysentery (2000-09-19),

10. 6107282 - Treatment of C. difficile toxin B associated conditions (2000-08-22),

11. 6087339 - Saccharide derivatives (2000-07-11),

12. 6069137 - Treatment of traveller's diarrhea (2000-05-30),

13. 6063769 - 1-thiogalactose derivatives (2000-05-16),

14. 6054047 - Apparatus for screening compound libraries (2000-04-25),

15. 6013635 - Treatment of C. difficile toxin B associated conditions (2000-01-11),

Synsorb Biotech, Inc. is a biotechnology company based in Calgary, Canada, specializing in the development of innovative therapeutic solutions. The organization focuses on addressing unmet medical needs through its expertise in biopharmaceuticals and advanced drug delivery systems. With a commitment to research and development, Synsorb aims to create effective treatments that enhance patient outcomes, leveraging cutting-edge technology in the biotechnological landscape.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

34 Patents

#21 in Calgary

#397 in Canada

#19,594 in the World

Calgary, Canada

Synsorb Biotech, Inc.

Forward Citations = 123

25 inventors:

Glen D Armstrong (20 out of 38 patents)

Louis D Heerze (13 out of 21 patents)

Ole Hindsgaul (11 out of 29 patents)

4. Bradley G Thompson (3 out of 151 patents)

5. David J Rafter (3 out of 3 patents)

Please report any incorrect information to [email protected]

Loading…